Overweight patients are more susceptible for acute liver failure

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1516-1520

  Canbay, Ali ^a,d   Chen, Shi Yao ^a   Gieseler, Robert K ^b,c   Malago, Massimo ^a   Karliova, Marc ^a   Gerken, Guido ^a   Broelsch, Christoph E ^a   Treichel, Ulrich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b LTBH Medical Research Institute   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Drug toxicity; Ethanol abuse; Fatty liver; Non alcoholic steatohepatitis; Obesity; Pre existing liver disease; Viral hepatitis

Indexed keywords

ADULT; AGE; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG TOXICITY; FEMALE; GENDER; HUMAN; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; VIRUS HEPATITIS;

ADULT; BODY MASS INDEX; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 25844520517     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Schiodt FV, Davern TJ, Shakil AO, McGuire B, SG Lee WM: Viral hepatitis-related acute liver failure. Am J Gastroenterol 2003; 98:448-453.
2. Shakil, AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J: Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-169.
3. O'Grady JG, Schalm SW, Williams R: Acute liver failure: Redefining the syndromes. Lancet 1993; 342:273-275.
4. Teo EK, Han SH, Terrault N, Luketic V, Jensen D, Keeffe EB, Lok AS: Liver transplantation in patients with hepatitis b virus infection: Outcome in asian versus white patients. Hepatology 2001; 34:126-132.
5. Williams R: Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996; 16:343-348.
6. Ruhl CE, Everhart JE: Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the united states. Gastroenterology 2003; 124:71-79.
7. Strauss R: Perspectives on childhood obesity. Curr Gastroenterol Rep 2002; 4:244-250.
8. Clark JM, Brancati FL, Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the united states. Am J Gastroenterol 2003; 98:960-967.
9. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C: Prevalence of and risk factors for hepatic steatosis in northern italy. Ann Intern Med 2000; 132:112-117.
10. James O, Day C: Non-alcoholic steatohepatitis: Another disease of affluence. Lancet 1999; 353:1634-1636.
11. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43:26-31.
12. Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA: Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003; 125:1053-1059.
13. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
14. Nomura F, Nakano M, Ohnishi K, Ohto M, Yamazaki K, Kawamura II, Isono K: Hepatic abnormalities in obesity: Comparison between mildly obese cases and morbidly obese cases. Obes Surg 1992; 2:41-45.
15. Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12:1106-1110.
16. Olusi SO: Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26:1159-1164.
17. O'Grady JG, Williams R: Classification of acute liver failure. Lancet 1993; 342:743.
18. Sorkine P, Ben Abraham R, Szold O, Biderman P, Kidron A, Merchav H, Brill S, Oren R: Role of the molecular adsorbent recycling system (mars) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29:1332-1336.
19. Conn HO: Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalo-pathy. Am J Dig Dis 1977; 22:541-550.
20. Manson JE, Willett, WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 1995; 333:677-685.
21. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM: Results of a prospective study of acute liver failure at 17 tertiary care centers in the united states. Ann Intern Med 2002; 137:947-954.
22. Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok AS: Hepatitis B infection in patients with acute liver failure in the united states. Hepatology 2001; 33:972-976.
23. Hoofnagle JH, Carithers RL Jr., Shapiro C, Ascher N: Fulminant hepatic failure: Summary of a workshop. Hepatology 1995; 21:240-252.
24. Lee WM: Acute liver failure. N Engl J Med 1993; 329:1862-1872.
25. Ostapowicz G, Lee WM: Acute hepatic failure: A western perspective. J Gastroenterol Hepatol 2000; 15:480-488.
26. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ: Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal alt values. Hepatology 2003; 37:1286-1292.
27. Lefilliatre P, Villeneuve JP: Fulminant hepatitis a in patients with chronic liver disease. Can J Public Health 2000; 91:168-170.
28. Hoffmeister H, Mensink GB, Stolzenberg H: National trends in risk factors for cardiovascular disease in Germany. Prev Med 1994; 23:197-205.
29. Kalies H, Lenz J, von Kries R: Prevalence of overweight and obesity and trends in body mass index in German pre-school children, 1982-1997. Int J Obes Relat Metab Disord 2002; 26:1211-1217.
30. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome x in severe obesity. J Clin Endocrinol Metab 1999; 84:1513-1517.
31. El-Serag HB, Everhart JE: Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002; 122:1822-1828.
32. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM: Alterations in liver atp homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999; 282:1659-1664.
33. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ: Diet associated hepatic steatosis sensitizes to fas mediated liver injury in mice. J Hepatol 2003; 39:978-983.
34. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T: Liver fibrosis in overweight patients. Gastroenterology 2000; 118:1117-1123.
35. Riegler G, D'Inca R, Sturniolo GC, Corrao G, Del Vecchio Blanco C, Di Leo V, Carratu, R, Ingrosso M, Papi MA, Morini S, Valpiani D, Cantarini D, Usai P, Papi C, Caprilli R: Hepatobiliary alterations in patients with inflammatory bowel disease: A multicenter study. Caprilli & gruppo italiano studio colon-retto. Scand J Gastroenterol 1998; 33:93-98.
36. Eade MN, Cooke WT, Brooke BN: Liver disease in ulcerative colitis. Lancet 1970; 2:718.
37. Schrumpf E, Fausa O, Elgjo K, Kolmannskog F: Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 1988; 8:201-209.
38. Schiodt FV, Rochling FA, Casey DL, Lee WM: Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997; 337:1112-1117.
39. Zimmerman HJ, Maddrey WC: Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 1995; 22:767-773.